COVID-19 does appear to increase the risk of developing diabetes. The link has shown up consistently across large studies in both adults and children, and researchers have identified several biological pathways that explain how the virus could disrupt blood sugar control. In some cases, the diabetes is temporary and resolves after recovery. In others, it persists and requires ongoing management.
How COVID-19 Damages Insulin-Producing Cells
The virus that causes COVID-19 enters human cells by latching onto a protein called ACE2. This protein is found throughout the body, but it’s expressed at especially high levels in the pancreas, even higher than in the lungs. Within the pancreas, the cells most vulnerable are beta cells, which are responsible for producing insulin. The virus has been shown to specifically infect these beta cells both in lab settings and in pancreatic tissue from COVID-19 patients.
What happens next is particularly concerning. Once infected, beta cells don’t simply die off. Many of them appear to lose their identity, reverting to an immature state where they can no longer produce insulin properly. Researchers have found that infected cells still carry markers identifying them as beta cells, but they stop expressing the hormones they’re supposed to make. This process, called dedifferentiation, represents a distinct way the virus can impair blood sugar regulation beyond just killing cells outright.
Beta cells also have additional entry points that other pancreatic cells lack. Two proteins, NRP1 and TFRC, are selectively expressed on beta cells at relatively high levels, giving the virus extra ways to get inside. This helps explain why the virus targets insulin-producing cells so specifically while leaving neighboring hormone-producing cells largely unaffected.
Inflammation and Insulin Resistance
Direct damage to the pancreas is only part of the story. During a COVID-19 infection, the immune system can release a flood of inflammatory molecules. While any serious infection can temporarily impair the body’s ability to use insulin, this effect appears to be more pronounced with COVID-19. The intense inflammatory response characteristic of severe cases can both damage beta cells and make the body’s tissues less responsive to insulin at the same time, a double hit to blood sugar control.
There’s also an autoimmune dimension. In one study of non-diabetic COVID-19 patients, about 4% developed autoantibodies against their own pancreatic cells. These are the same type of immune markers seen in autoimmune (type 1) diabetes, where the body’s immune system mistakenly attacks its own insulin-producing cells. The autoantibodies persisted beyond the initial infection, raising the possibility that COVID-19 could set an autoimmune process in motion that unfolds over months or years.
Who Is Most at Risk
Children and adolescents have drawn particular attention. A large observational study published in JAMA Network Open found that kids were one and a half times more likely to be diagnosed with type 2 diabetes in the months after COVID-19 compared to children who had other respiratory infections. Children with obesity faced double the risk, and those whose COVID-19 was severe enough to require hospitalization were nearly three times as likely to develop new diabetes.
A CDC analysis of pediatric data found that among children with both COVID-19 and a new diabetes diagnosis, nearly half had diabetic ketoacidosis (a dangerous complication where the body starts breaking down fat for fuel) at or around the time of diagnosis. Before the pandemic, only about 28% of new type 1 diabetes cases in children presented with this complication. The higher rate suggests that COVID-related diabetes may come on faster or more aggressively than typical cases.
For adults, the risk factors mirror those for diabetes in general: higher body weight, older age, and pre-existing metabolic issues all increase vulnerability. Severe COVID-19 requiring hospitalization carries a higher risk than mild illness.
Temporary vs. Lasting Diabetes
One of the most important things to understand is that post-COVID diabetes doesn’t always stick around. Among patients who developed new high blood sugar during a COVID-19 hospitalization, about 63% returned to normal glucose levels within six months. Roughly 35% continued to have elevated blood sugar, and about 2% received a formal diabetes diagnosis. The trajectory seems to depend on how much permanent damage the beta cells sustained. If enough functional cells remain, blood sugar regulation can recover.
COVID-triggered type 1 diabetes follows a similar pattern in some cases. When the autoimmune attack or direct viral damage isn’t extensive enough to wipe out beta cell function entirely, the condition can improve substantially or even resolve completely over time. But there’s currently no reliable way to predict at the outset which patients will recover and which will need long-term treatment.
Symptoms Worth Paying Attention To
The classic signs of developing diabetes are the same whether or not COVID triggered it: increased thirst, frequent urination, unexplained weight loss, fatigue, and blurred vision. What makes post-COVID diabetes tricky is that some of these symptoms, especially fatigue, overlap heavily with long COVID itself. Persistent tiredness after COVID is extremely common and doesn’t necessarily point to diabetes.
The more specific red flags are the ones tied to blood sugar: unusual thirst that doesn’t go away, needing to urinate much more frequently (especially at night), and losing weight without trying. In children, watch for a sudden return of bedwetting, increased irritability, or a fruity smell on the breath, which can signal ketoacidosis. These symptoms can emerge weeks to months after the initial infection, so they’re easy to miss if you’re not looking for them.
Monitoring Blood Sugar After COVID
Blood sugar abnormalities have been detected in recovered COVID-19 patients for at least two months after infection, and the six-month mark appears to be a meaningful checkpoint. By that point, most people whose blood sugar was going to normalize have done so, while those heading toward persistent diabetes are generally identifiable.
If you had a moderate to severe case of COVID-19, keeping an eye on your blood sugar in the months afterward is reasonable. This is especially true if you already had risk factors for diabetes before your infection, such as higher body weight, a family history of diabetes, or a history of prediabetes. A simple fasting glucose or HbA1c test from your doctor can catch problems early, and early detection makes a meaningful difference in how effectively diabetes can be managed.
For parents of children who’ve had COVID-19, particularly those with obesity or a family history of diabetes, staying alert to the symptoms described above in the six months following infection is a practical step. The overall risk remains low for any individual child, but the elevated risk compared to other respiratory infections is real enough to warrant attention.